MARKSANS PHARMA LTD.
BSE: 524404
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 321.19-11.2% | 361.57+6.4% | 339.73+6.0% | 320.44+0.2% | 319.73+6.8% | 299.36-4.0% | 311.87+1.0% | 308.63 |
| Other Income | 17.47-36.4% | 27.48+73.3% | 15.86-72.7% | 58.19+2795.0% | 2.01-74.3% | 7.82-65.3% | 22.51-28.2% | 31.36 |
| Total Income | 338.66-13.0% | 389.05+9.4% | 355.59-6.1% | 378.63+17.7% | 321.74+4.7% | 307.17-8.1% | 334.37-1.6% | 339.98 |
| EXPENSES | ||||||||
| Expenditure | 248.20-6.2% | 264.69-3.2% | 273.47+6.4% | 257.14-0.4% | 258.17+0.3% | 257.27-0.9% | 259.65-1.5% | 263.64 |
| Tax | 21.42-34.0% | 32.44+53.0% | 21.20-2.2% | 21.69+39.8% | 15.52+26.0% | 12.31-36.1% | 19.26+46.6% | 13.13 |
| PROFIT | ||||||||
| PBT | 90.46-27.3% | 124.36+51.4% | 82.12-32.4% | 121.49+91.1% | 63.57+27.4% | 49.90-33.2% | 74.72-2.1% | 76.34 |
| Net Profit | 69.04-24.9% | 91.92+50.9% | 60.91-39.0% | 99.81+107.7% | 48.06+27.8% | 37.59-32.2% | 55.46-12.2% | 63.20 |
| KEY METRICS | ||||||||
| OPM % | 25.56%-3.75pp | 29.31%+7.10pp | 22.21%-0.28pp | 22.49%+0.58pp | 21.91%+5.02pp | 16.89%+2.62pp | 14.27%+2.06pp | 12.21% |
| NPM % | 20.39%-3.24pp | 23.63%+6.50pp | 17.13%-9.23pp | 26.36%+11.42pp | 14.94%+2.70pp | 12.24%-4.35pp | 16.59%-2.00pp | 18.59% |
| EPS | 1.52-25.1% | 2.03+51.5% | 1.34-39.1% | 2.20+107.5% | 1.06+27.7% | 0.83-32.0% | 1.22-12.2% | 1.39 |
Corporate Events
Board Meeting
The 34th Annual General Meeting will be held on Thursday, Au…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company will be…
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the 34th Annu…
BSE Filing ↗Board Meeting
consider and approve quarterly results, consider and approve…
BSE Filing ↗Board Meeting
consider and approve quarterly results for the Quarter, cons…
BSE Filing ↗Board Meeting
consider and approve financial results for the quarter, cons…
BSE Filing ↗Board Meeting
Consider and approve the Audited Financial Results of the Co…
BSE Filing ↗Board Meeting
consider and approve unaudited financial results
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Financial Results
BSE Filing ↗Board Meeting
Consider and approve the unaudited financial results
BSE Filing ↗Board Meeting
Consider and approve unaudited financial results of the Comp…
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Financial Results (both S…
BSE Filing ↗